LotanR.Evaluation of the results of clinical trials with retinoids in relation to their basic mechanism of action. In: WattenbergL., ed. Cancer Chemoprevention.Boca Raton, Fla: CRC Press; 1992: 71–75.
8.
AdamsonP.C.Pharmacokinetics of alltransretinoic acid: clinical implications in acute promyelocytic leukemia. Semin Hematol.1994; 31(4 suppl 5): 1417.
9.
FrankelS.R., MillerW.H.Jr, DmitrovskyE.Retinoic acid and its rearranged receptor in the etiology and treatment of acute promyelocytic leukemia. Oncology.1992; 6: 7478.
10.
HuangM.E., YeE.C., ChenS.R.Use of alltrans retinoic acid in the treatment of acute promyelocytic leukemia. Blood.1988; 72: 567572.
11.
FenauxP., Le DeleyM.C., CastaigneS.Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicenter randomized trial. Blood.1993; 82: 32413249.
12.
FrankelS.R., EardleyA., HellerG.Alltrans retinoic acid for acute promyelocytic leukemia: results of the New York Study. Ann Intern Med.1994; 120: 278286.
13.
VendittiA., StasiR., CoppetelliU.All trans retinoic acid (ATRA): effective therapy even for ANLL other than APL? Evaluation of association with lowdose cytosine arabinoside (LDARAc). Blood.1993; 82(suppl 1): 2186.
14.
LippmanS.M., KesslerJ.F., MeyskensF.L.Jr. Retinoidsas preventive and therapeutic anticancer agents. Cancer Treat Rep.1984; 71: 391–405, 493515.
ZachariaeH., ThestrupPedersonK.Interferon alpha and etretinate combination treatment of cutaneous Tcell lymphoma. J Invest Dermatol.1990; 95(suppl 6): 206S–208S.
17.
HarrisonP., ChippingP., FothergillG.A.Successful use of alltrans retinoic acid in acute promyelocytic leukaemia presenting during the second trimester of pregnancy. Brit J Haematol.1994; 86: 681682.
18.
StentoftJ., NielsenJ.L., HvidmanL.E.Alltrans retinoic acid in acute promyelocytic leukemia in late pregnancy. Leukemia.1994; 8(suppl 2): S77–S80.
19.
de LacerdaJ.F.Toxicity of tretinoin in acute promyelocytic leukaemia. Lancet.1994; 343: 360361.
LimentaniS.A., PretellJ.O., PotterD.Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with alltrans retinoic acid. Am J Hematol.1994; 47: 5055.
22.
HashimotoS., KoikeT., TatewakiW.Fatal thromboembolism in acute promyelocytic leukemia during alltrans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis if hemorrhage. Leukemia.1994; 8: 11131115.
23.
FrankelS.R., EardleyA., LauwersG.The “retinoic acid syndrome” in acute promyelocytic leukemia. Ann Intern Med.1992; 117: 292296.
24.
WarrellR.P.Jr. In response: fatal alltrans retinoic acid pneumonitis. Ann Intern Med.1993; 118: 473.
25.
CastaigneS., LefebvreP., ChomienneC.Effectiveness and pharmacokinetics of lowdose alltrans retinoic acid (25 mg/m2) in acute promyelocytic leukemia. Blood.1993; 82: 35603563.
